![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 44, 41931-41939, November 1, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
From the
Department of Biochemistry and Biophysics,
Arrhenius Laboratories for Natural Sciences, Stockholm University,
106 91 Stockholm, Sweden, the § Department of Plant
Biology, Cornell University, Ithaca, New York 14853, and the
¶ Department of Cell Biology and Biochemistry, Research Area
Cardiovascular Gastrointestinal, AstraZeneca R & D Mölndal,
S-431 83 Mölndal, Sweden
Received for publication, June 4, 2002, and in revised form, July 18, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Most of the nuclear encoded mitochondrial
precursor proteins contain an N-terminal extension called the
presequence that carries targeting information and that is cleaved off
after import into mitochondria. The presequences are amphiphilic,
positively charged, membrane-interacting peptides with a propensity to
form Most mitochondrial proteins are encoded by nuclear genes,
synthesized on cytosolic polyribosomes as precursor proteins, and imported into mitochondria post-translationally. Precursor proteins contain a cleavable peptide extension at the N terminus, called presequence or targeting or signal peptide (for reviews see Refs. 1 and
2). The presequences contain information necessary for targeting and
are required at all steps along the mitochondrial protein import
pathway (3, 4). In the cytosol, nascent polypeptide chains and
presequences interact with molecular chaperones. Presequences are
further recognized by specific receptors on the outer membrane of
mitochondria (5, 6). The protein import machinery of mitochondria, the
translocases of the outer and the inner membrane, contain a series of
proteins that successively interact with the presequences (4, 7). The
mitochondrial Hsp70 is the primary target protein for the presequence
protruding into the matrix (8). Finally, the presequence is cleaved off
by the mitochondrial processing peptidase (MPP)1 (9, 10),
and the mature protein is folded and assembled upon action of molecular
chaperones into oligomeric protein complexes.
The great majority of mitochondrial presequences (>80%) are in the
range of 20-60 residues; however, the length varies substantially from
6 residues for ATP synthase F chain from yeast to 136 residues for
Glycine max cytochrome c oxidase subunit 2 (Cox2)
(11, 12). Presequences do not show amino acid sequence similarity, but
they have characteristic physicochemical properties. They are enriched in positively charged, hydroxylated, and hydrophobic residues and have
the potential to form an amphiphilic Several research groups (19-21) have reported severe effects of
presequence peptides on the structural and functional integrity of
mitochondrial membranes. Presequence peptides can perturb natural and
artificial lipid bilayers. Addition of presequences to mitochondria results in membrane lysis, uncoupling of respiration, and dissipation of the membrane potential (14, 22, 23). The mechanism of action for
membrane-permeabilizing peptides is not clear, but it has been proposed
that the presequence peptides induce a channel (24) or that the
peptides themselves form a pore (25). Furthermore, peptides derived
from mitochondrial presequences have been shown to be lethal toward
Bacillus megaterium at micromolar concentrations (26). To
avoid the potential harmful interactions of presequences with
mitochondrial membranes, presequences cleaved off from precursor proteins inside mitochondria should be removed either by degradation inside mitochondria or by export out from the organelle.
By using chemical quantities of the presequence of the ATP synthase
F1 Several ATP-dependent proteases have been identified in
mitochondria that selectively remove non-assembled or misfolded
polypeptides (34). The quality control of the mitochondrial inner
membrane is ensured by the ATP and metal- dependent AAA
proteases, Yme1p, Yta10p, and Yta12p, homologues of the bacterial FtsH
proteases (35). Yme1p, Yta10p, and Yta12p have been identified in
Neurospora crassa, yeast, and mammalian mitochondria
(36-38). The PIM1 protease, a homologue of the bacterial Lon protease,
is located in the mitochondrial matrix and has overlapping substrate
specificities with the AAA proteases (39, 40). Lon-like proteases have
been found in the mitochondria of yeast and mammals (41, 42). Maize
mitochondria contain a Lon protease that is loosely associated to the
inner membrane (43). Homologues of the bacterial ClpP protease have also been identified in the matrix of mammalian and plant mitochondria (44, 45). However, no proteolytic function or natural substrates have
been identified for ClpP in mitochondria. Both PIM1 and ClpP are
ATP-dependent serine-type proteases. All the
ATP-dependent proteases in mitochondria are assembled into
large multimeric protein complexes and harbor not only the proteolytic
but also chaperone activity (45, 46).
Studies from our laboratory (27) revealed that the presequence of
F1 Purification of a Novel Metalloprotease from Solanum tuberosum
Mitochondria--
Potato tuber mitochondria were isolated as described
previously (47). The mitochondria were diluted with 20 mM
HEPES-KOH (pH 8.0) and 30 mM MgCl2 to a protein
concentration of 8 mg/ml and sonicated for 3 × 15 s at
4 °C. Matrix was separated from membranes by centrifugation at
200,000 × g for 30 min. The supernatant was filtered
through a 0.2-µm membrane and applied to an arginine-Sepharose (Amersham Biosciences) affinity column equilibrated with 20 mM HEPES-KOH (pH 8.0). Bound proteins were eluted from the
column with a linear gradient of 0-0.5 M NaCl. The
proteolytically active fractions were pooled, desalted on a PD-10
column, loaded onto a Mono Q HR 5/5 (Amersham Biosciences), and
equilibrated with 20 mM HEPES-KOH (pH 8.0). Bound proteins
were eluted from the Mono Q anion exchanger with a linear gradient of
0-0.4 M NaCl. The active fraction was desalted on a PD-10
column and applied to a Mini Q PE 4.6/50 (Amersham Biosciences),
equilibrated with 20 mM HEPES-KOH (pH 8.0). Bound proteins
were eluted from the Mini Q anion exchanger with a linear gradient of
0-0.4 M NaCl. The active fraction eluted from the Mini Q
column was desalted on PD-10 and concentrated.
Two-dimensional Gel Electrophoresis--
Samples containing
proteolytic activity (150 µl, 1.8 mg/ml) were diluted to a final
volume of 250 µl with a solution containing 7 M urea, 2 M thiourea, 4% (w/v) CHAPS, 100 mM DTT, and
2% (v/v) carrier ampholytes (IPG buffer (pH 3-10), Amersham
Biosciences) and applied to a nonlinear IPG strip, pH 3-10. The strips
were allowed to rehydrate overnight at 20 °C and were then
transferred to IPG strip holders and covered with paraffin oil.
Proteins were focused for 1 h at 150, 500, and 1,000 V followed by
a stepwise increased gradient to 8,000 V. The isoelectric focusing was
then completed at a constant voltage of 8,000 V until 80,000 V-h were reached. Subsequently, the strips were first equilibrated for 15 min in
50 mM Tris-HCl (pH 6.8), 6 M urea, 30% (v/v)
glycerol, 2% SDS (w/v), and 10 mg/ml DTT and then for 10 min in the
same buffer without DTT but with 25 mg/ml iodoacetamide and a trace of
bromphenol blue. In the second dimension, 12% SDS-PAGE was carried out according to Laemmli (48). Proteins were stained with Coomassie Brilliant Blue R-250.
In-gel Digestion, Sample Preparation, Mass Spectrometry, and Data
Base Search--
Protein spots were excised from the Coomassie-stained
gel and put in a 96-well PCR plate. In-gel digestion was performed
according to Lanne et al. (49) with some modifications as
follows: gel pieces were washed with water and 35% acetonitrile
followed by dehydration in a SpeedVac vacuum evaporator. The gel plugs
were digested with trypsin and extracted by addition of 1% formic
acid, 1% acetonitrile. The digests were then analyzed by MALDI-TOF MS on a Voyager-DE STR mass spectrometer in reflector mode
(Perspective Biosystems) with Substrate Preparations--
The precursor of the
F1 Protease Activity--
The proteolytic activity was determined
by degradation of N5.7pF1 Protein Content--
The polypeptide content of the
mitochondrial matrix and isolated chromatographic fractions was
analyzed by 12-20% SDS-PAGE in the presence of 4 M
urea (48). Proteins were stained with silver.
Purification of a Mitochondrial Protease That Degrades
Mitochondrial Presequences--
In order to assay degradation of
mitochondrial presequences, we have prepared chemical amounts of a
truncated precursor derived from the overexpressed full-length
precursor of the F1 Identification of the Protease, Two-dimensional Gels, and Mass
Spectrometry--
To identify the protease among the polypeptides in
the MiQ2 fraction, two-dimensional gels followed by MALDI-TOF and
ESI-MS/MS were applied. The two-dimensional gel of the MiQ2 fraction
revealed nine individual protein spots; two high molecular mass
proteins (105 and 91 kDa), five proteins in the range of 55-70 kDa, a
35-kDa protein, and Mn-SOD (23 kDa) (Fig.
3). The molecular masses of proteins
separated in one or two dimensions differ slightly from each other.
This is due to the presence of urea in the one-dimensional SDS-PAGE
system. MALDI-TOF followed by data base search allowed identification
of the proteins in the 55-70-kDa range as the F1
In order to identify the 105- and 91-kDa proteins, we performed
ESI-MS/MS analysis to obtain sequence information in combination with
molecular masses. ESI-MS/MS identified the 91-kDa protein as a putative
Hsp90 from A. thaliana (Table I). Subcellular prediction programs identified the putative Hsp90 as a mitochondrial protein. Hsp90 has also been found in human mitochondria (62). No proteolytic activity has been reported for Hsp90. The 18-amino acid residues sequence of the peptide derived from the 105-kDa protein (Fig. 4 and Table I) matched four proteins in
the NCBI data base, a zinc metalloprotease (insulinase family)
(BAB02957), a putative zinc metalloprotease (AAG13049), and two
putative hydrogenases (AAL67002 and NP_175386). The sequences of the
putative zinc metalloprotease and the putative hydrogenases display
99% sequence identity and only differ in a stretch of 10 amino acids
located in positions 189-199 from the predicted cleavage site. These
protein sequences are derived from the same gene
(At1g49630) on chromosome 1 and therefore refer to
the same protein reported three times in the NCBI data bases that will be referred to here as a putative zinc metalloprotease. The gene for
the zinc metalloprotease (At3g19170) is located on
chromosome 3. The putative zinc metalloprotease and the zinc
metalloprotease display 89% sequence identity and 95% sequence
similarity (Fig. 4), with most differences in the predicted targeting
sequences. The targeting peptide of zinc metalloprotease is 30 amino
acids shorter than the targeting peptide of the putative zinc
metalloprotease. However, an EST clone of zinc metalloprotease from
A. thaliana containing an additional 30 amino acid
N-terminal region has been reported from the RIKEN Genomic Science
Center and the Kazusa DNA Research Institute, Japan. The overexpressed
A. thaliana zinc metalloprotease revealed proteolytic
activity against the presequence peptide.2 By using MitoProt,
both proteases are predicted to contain a mitochondrial presequence
with an arginine in position Characterization of PreP, a Novel Mitochondrial
Metalloprotease--
We investigated if the purified protease was
capable of degrading substrates other than the F1
The effect of protease inhibitors on degradation of
N5.7pF1 Mitochondrial targeting presequences are potentially harmful to
the structure and function of mitochondria as they can disrupt biological membranes, dissipate membrane potential, and cause severe
mitochondrial dysfunctions (19, 21, 22). Therefore, it is generally
believed that after protein import and processing, the presequences are
degraded inside mitochondria. However, virtually nothing is known about
the degradation process or proteases involved in the degradation.
Difficulties studying the fate of targeting peptides have come from the
fact that small quantities of in vitro transcribed and
translated precursors have been used in protein import studies. We have
used chemical quantities of a precursor protein, and we were able for
the first time to visualize degradation of a presequence inside
mitochondria. We have shown that the presequence of the
F1 The current investigation aimed to identify and characterize
mitochondrial protease(s) involved in presequence degradation. We have
developed a simple chromatographic procedure for the isolation of the
protease(s). The first step of the procedure included purification on
an affinity column that contained arginines coupled to Sepharose (arginine-Sepharose). Because mitochondrial presequences are enriched in positively charged residues, arginines and lysines, the idea was to
use a positively charged chromatographic gel matrix to bind potential
protease candidates that would bind to presequences, in
situ. Further purification was achieved by ion exchange
chromatography, on Mono Q and high resolution Mini Q anion exchangers.
The proteolytic activity of the isolated fraction was enriched by
several hundredfold in comparison to the matrix. The two-dimensional
gel of the purified proteolytically active fraction from the Mini Q
column revealed nine individual proteins, six of which were identified
by MALDI-TOF as mitochondrial Hsp70, flavoprotein of succinate
dehydrogenase, dihydrolipoamide dehydrogenase, the F1 Homologues of the zinc metalloprotease are present in human and in
yeast. Subcellular prediction programs suggest that both homologues are
localized to mitochondria. Alignments of the A. thaliana
zinc metalloprotease and non-plant eucaryotic homologues revealed 30%
sequence identity and a fully conserved inverted zinc-binding motif.
The human homologue of 110 kDa (hMP1) was found to be sensitive to
metal chelators and thiol reagents and was highly expressed in
mitochondrial enriched tissues such as heart and skeletal muscles (67).
The homologue identified in yeast is a hypothetical 989-amino acid long
protein (Ydr430cp). In yeast gene deletion studies, Ydr430cp was not
found to be essential (68). No lethal phenotypes have been reported for
mitochondrial proteases or their bacterial homologues (46, 68, 69). The absence of severe phenotypes for mitochondrial proteases suggests overlapping substrate specificities between the proteases, for example,
shown for the PIM1 and the matrix-AAA proteases (40). The
identification of the zinc metalloprotease homologues in various types
of mitochondria might indicate that it is a general protease involved
in the degradation of cleaved presequences peptides inside mitochondria.
The mitochondrial ATP-dependent proteases with different
sub-organellar locations generate oligopeptides upon catalysis.
Proteolysis by the membrane-bound AAA proteases generates small
peptides with molecular masses of 2100 to 600 Da (70). In the matrix,
the PIM1 protease degrades proteins to products containing 5-15 amino acid residues (71). In E. coli, ClpP hydrolyzes a number of proteins by endoproteolysis to generate short acid-soluble peptides (69). ClpP has been identified in the matrix of mitochondria; however,
no native substrates or ClpP proteolytic activity have been
demonstrated (44, 45). Incubation of PreP with the presequence of
F1 Further characterization of PreP was performed using synthetic
cleavage-specific fluorescent peptides, P1 (11 amino acids) and P2 (7 amino acids). Like mitochondrial presequences, the peptides contained
basic and hydrophobic residues and no negatively charged residues. Only
the longer P1 peptide was degraded by PreP. This indicates that a
minimal peptide length or specific amino acids might be required for
efficient proteolysis by the PreP protease. The exact prerequisites for
proteolysis still need to be determined. The proteolytic activity was
investigated in the presence of inhibitors affecting different protease
classes such as metallo, carboxy, serine, and cysteine proteases. The
chelator o-phenanthroline completely inhibited the
degradation of the F1 Can presequences be exported from mitochondria? A signal peptide was
found to be exported from the endoplasmic reticulum membrane and
interacted with calmodulin (73). The binding of signal peptides to
calmodulin suggests that signal peptides contribute in regulation of
cellular reactions (73). In yeast the ATP-binding cassette protein Mdl1
was shown to be involved in export of peptide fragments generated by
proteolysis of the inner membrane AAA proteases (70). However, the
majority (70%) of the released products from mitochondria were
recovered as free methionine (70). Due to high energy costs and low
export efficiency of peptides to the outside of mitochondria, presequences are more likely to be degraded inside mitochondria. Amino
acids recovered from the degraded presequences can be used for
mitochondrial protein synthesis or further catabolized via the urea
cycle. Mitochondrial presequences are enriched in arginines that can be
a precursor for synthesis of nitric oxide, polyamines, and other
biologically active compounds. The arginine-converting enzymes like
arginase and nitric-oxide synthase have been identified in mitochondria
(74, 75). Arginines that are released upon presequence degradation can
be converted into nitric oxide and regulate transcription of nuclear
encoded mitochondrial genes, thereby providing cross-talk between
mitochondria and the nucleus.
-helices. Here we have investigated the proteolysis of the
presequences that have been cleaved off inside mitochondria. A
presequence derived from the overexpressed F1
subunit of the ATP synthase and specific synthetic fluorescent peptides
(Pep Tag Protease assay) have been shown to undergo rapid degradation
catalyzed by a matrix located protease. We have developed a three-step
chromatographic procedure including affinity and anion exchange
chromatography for isolation of the protease from potato tuber
mitochondria. Two-dimensional gel electrophoresis of the isolated
proteolytically active fraction followed by electrospray
ionization-mass spectrometry/mass spectrometry and data base searches
allowed identification of the presequence peptide-degrading protease in
Arabidopsis thaliana data base as a novel mitochondrial
metalloendoprotease with a molecular mass of 105 kDa. The
identified metalloprotease contains an inverted zinc-binding motif and
belongs to the pitrilysin family.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-helical structure (13, 14).
Synthetic peptides derived from mitochondrial presequences have been
shown to bind to lipid vesicles containing anionic phospholipids as
amphiphilic helical structures (15-17). The NMR structure of the Tom20
receptor in complex with a presequence peptide revealed that the bound
presequence forms an amphiphilic
-helical structure with a
hydrophobic surface that interacts with the hydrophobic patch in the
Tom20 groove (18).
subunit, we have reported previously (27)
experimental evidence for a rapid degradation of the presequence
in organello after in vitro import and
processing. There are a few reports suggesting that chemically
synthesized presequence peptides are degraded inside mitochondria (28,
29). The synthetic presequence peptide derived from CoxIV was imported
into rat mitochondria and found to be associated with the membrane;
however, the authors suggested that the peptide was further
translocated to the matrix and degraded over time (29). Another
chemically synthesized presequence peptide derived from cytochrome
P-450 was accumulated inside mitochondria only in the presence of a
chelating agent, o-phenanthroline (28-30). Subunit 9 of the
bovine cytochrome bc1 complex corresponds to the
presequence of the bovine Rieske iron-sulfur protein and is the
only known example of a presequence that is retained in the
mitochondria and integrated as a subunit of an oligomeric
membrane-bound protein complex (31). The precursor of the bovine Rieske
iron-sulfur protein is targeted and assembled into the
bc1 complex before the presequence is cleaved
off, presumably by the core proteins in the bc1
complex (31-33).
undergoes rapid degradation catalyzed by a matrix located protease(s). Here we have developed a three-step
chromatographic procedure for isolation of a protease involved in
presequence degradation. The proteolytic activity was measured by
immunological detection of the F1
presequence
degradation and by cleavage of synthetic fluorescent peptides.
Two-dimensional gel electrophoresis of the isolated fraction followed
by ESI MS/MS and data base searches allowed identification of the
presequence peptide-degrading protease in Arabidopsis
thaliana data base as a novel mitochondrial metalloprotease. The
identified metalloprotease contains an inverted zinc-binding motif and
belongs to the pitrilysin family.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-cyano-4-hydroxycinnamic acid as
matrix. To achieve accurate mass determination, calibration was
automatically performed using tryptic auto-digestion products as
internal standards for each sample. The obtained mass spectra were
annotated in Data Explorer, and the latest versions of NCBI
nonredundant data bases were searched with the resulting peptide mass
list, using the search engine MASCOT (www.matrixscience.com) or
Profound (prowl.rockefeller.edu/cgi-bin/ProFound). The remaining
peptide extracts were purified and concentrated on a column of PorosTM
20R packing material (Applied Biosystems). About 5 µl of sample was
applied onto the column and washed with 5% formic acid, and the
peptides were eluted with 2.5 µl of 65% acetonitrile and 0.5%
formic acid directly into the nanospray needle (Protana A/S). The
samples were analyzed by electrospray MS using a quadrupole
time-of-flight mass spectrometer (Micromass) equipped with a nanospray
interface. The MS/MS spectra were either used to search NCBI
nonredundant data bases with MASCOT directly or interpreted manually
using MassLynx and Pepseq (Micromass).
subunit of the mitochondrial ATP synthase,
pF1
, from Nicotiana plumbaginifolia
was overexpressed in Escherichia coli BL21(DE3). The
expressed protein was insoluble and present in inclusion bodies.
Isolated inclusion bodies were solubilized in 70% formic acid and
chemically cleaved with CNBr after methionine residues. The sample was
evaporated and redissolved in 10 mM Tris-HCl (pH 8.0), 4 M urea, 1 mM DTT and loaded onto a Mini S
column. Elution was performed with a linear gradient of 0-0.5
M NaCl. Fractions containing the 15-kDa N-terminal fragment of pF1
, N15pF1
, were
collected. This polypeptide contains all information necessary for
mitochondrial targeting, import, and processing (47).
N15pF1
(0,01 nM) was cleaved
with purified MPP·bc1 complex from
Spinacia oleracea to generate the presequence of
N15pF1
. The presequence is 54 amino acid
residues long, has a molecular mass of 5.7 kDa, and is referred to as
N5.7pF1
-(2-54) (27). The presequence with a
modified C-terminal carboxylic group was prepared from a mutant
pF1
, in which a methionine was inserted at position +1
downstream of the MPP-processing site. The mutant protein was
overexpressed in E. coli and treated with CNBr to cleave
the presequence after the introduced methionine. During the cleavage
reaction the methionine was converted into a homoserine lactone (hsl)
group to generate N5.7pF1
-(2-54)-hsl (50).
Purification of N5.7pF1
-(2-54)-hsl was
performed as described above for N15pF1
.
-(2-54) that
was generated by cleavage of N15pF1
with
MPP·bc1 complex. For the proteolytic
reaction, precleaved N15pF1
(0,01 nM) was incubated with mitochondrial matrix (33 µg) or
isolated chromatographic fractions (30 µl) in a buffer containing 20 mM HEPES-KOH (pH 8.0), 1 mM MnCl2,
and 1% (v/v) Triton X-100 for 30 min at 30 °C. The reaction was
stopped by addition of sample buffer and analyzed on 12-20% SDS-PAGE
in the presence of 4 M urea (48). Immunological
cross-reactivity was analyzed by Western blotting using Hybond ECL that
was immunodecorated with antibodies raised against the C-terminal part
of the presequence (residue 38-54) of the pF1
, followed
by detection with horseradish peroxidase-labeled secondary antibodies.
Degradation of N5.7pF1
-(2-54)-hsl was
studied to assess the role of the free C terminus in proteolysis. The degradation assay contained
N5.7pF1
-(2-54)-hsl (0,01 nM)
and the isolated fraction from the Mini Q column (30 µl) and was
carried out for 30 min at 30 °C. The reaction was stopped, and
products were analyzed as described for the
N5.7pF1
-(2-54). To characterize the
protease, degradation of synthetic peptides was also studied. The
degradation assay contained 0.6 µg of the synthetic fluorescent peptides, P1 or P2 (Pep Tag Protease assay, SDS, Promega), and the
isolated fraction from the Mini Q column (30 µl). Degradation was
carried out at 30 °C for 30 min, and 80% glycerol was added. The
samples were analyzed directly on a 1% agarose gel, and the fluorescent peptides were visualized by UV light. The effect of protease inhibitors and ATP dependence of the proteolytic activity was
investigated using 1 mM phenylmethylsulfonyl fluoride, 1 mM N-ethylmaleimide, 10 mM
ortho-phenanthroline, 1 mM carboxypeptidase inhibitor (catalogue number 217359, Calbiochem), or 40 units/ml apyrase. The isolated fraction from the Mini Q column was preincubated for 10 min at 4 °C with protease inhibitors before addition of substrates. Both N5.7pF1
-(2-54) and the P1
peptide were used as substrates. To test proteolytic activity in the
presence of inhibitors, samples were incubated and analyzed as
described before.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
(pF1
) subunit of the
ATP synthase. The 15-kDa N-terminal fragment of pF1
,
designated as N15pF1
, consisted of a
53-amino acid long presequence and the first 82 amino acids of the
mature form and was detected by antibodies directed against the
C-terminal part of the presequence (47). The precursor protein was
incubated with the isolated spinach MPP·bc1
complex (51) to generate the presequence peptide of 5.7 kDa,
N5.7pF1
-(2-54) (Fig.
1B, lane 1). The
proteolytic activity was found to be localized to the matrix of
mitochondria (27). We have developed a three-step procedure for
purification of a protease involved in presequence degradation. The
procedure was based on affinity chromatography, followed by anion
exchange chromatography. Mitochondrial matrix from S. tuberosum was applied to an affinity column, arginine-Sepharose. The majority of proteins did not bind to the column (flow-through). Bound proteins were eluted with a linear gradient of 0-0.5
M NaCl and recovered in three protein peaks, A1 and A2 at
0.1-0.25 M NaCl and A3 at 0.25-0.35 M NaCl
(Fig. 1A). When the isolated fractions were analyzed for
proteolytic activity using N5.7pF1
-(2-54)
(Fig. 1B), the proteolytic activity was found in fractions
A1 and A2 (Fig. 1B, lanes 4 and 5). The protein
content of eluted fractions analyzed by SDS-PAGE revealed a similar
polypeptide pattern in fractions A1 and A2 (not shown) that were
pooled, desalted, and loaded onto a Mono Q column. Proteins eluted from
the Mono Q with a linear gradient of 0-0.4 M NaCl (Fig.
2A, upper panel)
exhibited two protein peaks, MoQ1 and MoQ2. The proteolytic activity
was eluted at 225-275 mM NaCl in fraction MoQ1 (Fig.
2B, lane 3). SDS-PAGE of MoQ1 revealed a major
band of 23 kDa as well as several other bands in the high molecular
mass region (Fig. 2C). MALDI-TOF analysis identified the 23 kDa as Mn2+-containing superoxide dismutase (Mn-SOD). In
order to separate Mn-SOD from potential protease candidates, an anion
exchanger, Mini Q, with a higher resolution capacity than Mono Q was
used in the purification procedure. Proteins bound to the Mini Q were eluted with a linear gradient of 0-0.4 M NaCl and
collected in two protein fractions MiQ1 and MiQ2 (Fig. 2A,
lower panel). The proteolytic activity was completely eluted
at 310-340 mM NaCl and found only in fraction MiQ2
(Fig. 2C, lane 6). As revealed by SDS-PAGE
in one dimension, fraction MiQ1 contained the 23-kDa Mn-SOD band (Fig.
2C), whereas MiQ2 contained 7 polypeptides: 2 high molecular
mass proteins (110 and 108 kDa), 4 proteins in the range of 55-66 kDa
(66, 65, 55, and 54 kDa), and residual amounts of Mn-SOD (23 kDa) (Fig.
2C). No proteolytic fragments of the presequence of
pF1
were detected after incubation with isolated
chromatographic fractions (Fig. 1B, lanes 4 and 5; Fig. 2B, lanes
3 and 6). In order to confirm complete degradation of the presequence, we used N5.7pF1
-(2-54)
that was labeled with sulfosuccinimidyl biotin at lysine residues and
detected using the avidin peroxidase system (27). There are 2 lysine
residues in the presequence of F1
at positions 32 and
44. Experiments with the sulfosuccinimidyl biotin-labeled
F1
presequence have not revealed any presequence
fragments indicating complete degradation of the presequence (not
shown).

View larger version (20K):
[in a new window]
Fig. 1.
Arginine-Sepharose chromatography.
A, elution profile from arginine-Sepharose. Mitochondrial
matrix was prepared from S. tuberosum and applied to the
column. Unbound proteins were removed by washing with 20 mM
HEPES-KOH, pH 8.0 (flow-through, FT). Bound proteins were
eluted from the affinity column with a linear gradient of 0-0.5
M NaCl (fractions A1-A3). The solid
line represents the absorbance at 280 nm, and the dashed
line represents the NaCl gradient. B, degradation of
the presequence of F1
(N5.7pF1
-(2-54)) with fractions from
arginine-Sepharose chromatography.
N5.7pF1
-(2-54) was obtained after cleavage
of N15pF1
with the isolated
MPP·bc1 complex (lane 1) and
further incubated with matrix (lane 2), flow-through
(FT, lane 3), or fractions A1, A2, and A3
(lanes 4-6) as described under "Experimental
Procedures."

View larger version (20K):
[in a new window]
Fig. 2.
Ion exchange chromatography.
A, elution profile from Mono Q (upper panel) and
Mini Q (lower panel). Active fractions from
arginine-Sepharose were applied to Mono Q. Bound proteins were eluted
from the anion exchanger with a linear gradient of 0-0.4 M
NaCl (fractions MoQ1 and MoQ2). The
proteolytically active fraction from Mono Q was desalted and loaded
onto Mini Q. Bound proteins were eluted from the anion exchanger with a
linear gradient of 0-0.4 M NaCl (fractions MiQ1
and MiQ2). The solid line represents the
absorbance at 280 nm, and the dashed line represents the
NaCl gradient. B, degradation of the presequence of
pF1
, N5.7pF1
-(2-54), with
fractions from ion exchange chromatography.
N5.7pF1
-(2-54) was obtained after cleavage
of N15pF1
with
MPP/bc1 (lane 1) and further
incubated with matrix (lane 2), or fractions MoQ1
(lane 3), MoQ2 (lane 4), MiQ1 (lane
5), and MiQ2 (lane 6) as described under
"Experimental Procedures." C, SDS-PAGE of fractions
eluted from anion exchangers. Proteins were stained with silver.
and
F1
subunits of ATP synthase (54 and 55 kDa), the
flavoprotein from succinate dehydrogenase (66 kDa), dihydrolipoamide
dehydrogenase (57 kDa), and mitochondrial Hsp70 (69 kDa) (Table
I). The F1
and
F1
subunits are a part of the extramembranous catalytic
core of the membrane-bound ATP synthase (52). Western blot
analysis revealed small contaminations of the F1
and
F1
subunits in the matrix preparations, <5%. Both the
flavoprotein from succinate dehydrogenase and dihydrolipoamide
dehydrogenase have been classified as soluble matrix proteins in
studies of A. thaliana mitochondrial proteome (53). Hsp70 is
one of the most conserved proteins and is described as a general
molecular chaperone (54). In mitochondria, Hsp70 is localized to the
matrix and drives mitochondrial import in an ATP-dependent
manner (55). Mn-SOD has been identified in the matrix of mitochondria
(53) and functions to neutralize produced oxygen radicals into
H2O2 (56). All the proteins identified by
MALDI-TOF analysis are conserved, abundant mitochondrial proteins with
a well characterized function. The three-dimensional structures have
been solved for the MALDI-TOF identified proteins or their protein
homologues, and no proteolytic sites or activities have been reported;
therefore, it allows the exclusion of them as protease candidates
(56-61). No MALDI-TOF spectra could be obtained from spot
number 9, neither could this spot be stained with silver.

View larger version (17K):
[in a new window]
Fig. 3.
Two-dimensional gel electrophoresis. The
proteins in fraction MiQ2 were resolved by SDS-electrophoresis in a
12% polyacrylamide gel subsequent to isoelectric focusing in a
nonlinear immobilized pH gradient from pH 3 to 10.
Proteins identified by mass spectrometry
2 upstream of the processing site, a
common characteristic of mitochondrial presequences. However, using
prediction programs that select preferable organellar localization,
Predator and TargetP, the zinc metalloprotease with the additional
30-amino acid N-terminal region is predicted to be localized to
mitochondria, whereas the putative metalloprotease was suggested to be
a chloroplastic protein. The inverted zinc-binding region is located in
the N-terminal portion of the protein and classifies the proteases to
the pitrilysin family. We have named the experimentally identified
metalloprotease that degrades targeting sequences as Presequence
Protease, PreP.

View larger version (80K):
[in a new window]
Fig. 4.
Sequence alignment of the zinc
metalloprotease (insulinase family) (BAB02957), a
putative zinc metalloprotease (AAG13049), and two
putative hydrogenases (AAL67002 and
NP_175386) from A. thaliana. The completely conserved residues are
colored in blue, and the conserved residues that are similar
are colored in green. The arrow indicates the
processing site predicted by Mitoprot. The inverted zinc-binding
region, HILEHX74E, is colored in
red, and the peptide identified by ESI MS/MS is colored in
yellow. Multiple sequence alignments were done using
ClustalW.
presequence. For this purpose we used synthetic, cleavage-specific
peptides, P1 and P2, labeled with a fluorescent dye. Both peptides
contained typical presequence elements like basic and hydrophobic
residues but no acidic residues (Fig.
5A). In the native state both
peptides are positively charged (Fig. 5, B and C,
lane 1), but upon cleavage, fragments of different sizes and
charges are generated that correspond to different cleavage sites.
Incubation of the fraction containing PreP and the P1 peptide produced
a negative charged fragment, indicating that the P1 peptide was cleaved
after Pro, Leu, or Ser (Fig. 5B, lane 2). In
contrast, the P2 peptide was not degraded by the PreP-containing
fraction (Fig. 5C, lane 2). These results may
reflect the requirement of a minimal peptide length or amino acid
content to initiate and pursue degradation.

View larger version (30K):
[in a new window]
Fig. 5.
Degradation of synthetic fluorescent peptides
by PreP-containing fraction. A, sequences of synthetic
fluorescent peptides P1 and P2. B, P1 peptide alone
(lane 1). P1 after incubation with PreP-containing fraction
(MiQ2) (lane 2) as described under
"Experimental Procedures." C, P2 peptide alone
(lane 1). P2 after incubation with PreP containing fraction
(lane 2) as described under "Experimental
Procedures."
-(2-54) and synthetic peptides by
PreP was evaluated (Fig. 6). Degradation
of N5.7pF1
-(2-54) was inhibited by
o-phenanthroline and carboxypeptidase inhibitor (Fig.
6A, lanes 5 and 6). The same protease
inhibitors also abolished degradation of the P1 peptide (Fig.
6B, lanes 5 and 6). No effect was
observed with phenylmethylsulfonyl fluoride,
N-ethylmaleimide, or apyrase. In order to determine whether
a free carboxyl group on presequences is required for their
degradation, we used a presequence with a blocked carboxyl group,
N5.7F1
-(2-54)-hsl. Despite the modified C
terminus, N5.7F1
-(2-54)-hsl was degraded by
the PreP-containing fraction (Fig. 7).
The carboxypeptidase inhibitor is a 38-amino acid residue peptide
isolated from potato that contains presequence characteristic amino
acids, 5 positively charged and 11 hydrophobic amino acids (63).
Therefore, the carboxypeptidase inhibitor peptide might function as a
competitive substrate for the protease.

View larger version (16K):
[in a new window]
Fig. 6.
Effect of inhibitors on the PreP
activity. A, degradation of the presequence of
pF1
, N5.7pF1
-(2-54), by
PreP-containing fraction (MiQ2) in the presence of
inhibitors. N5.7pF1
-(2-54) was obtained
after cleavage of N15pF1
with
MPP·bc1 complex (lane 1) and
further incubated with fraction MiQ2 (lane 2) or fraction
MiQ2 in the presence of inhibitors (lanes 3-7) as described
under "Experimental Procedures." B, degradation of the
P1 peptide by PreP-containing fraction in the presence of inhibitors.
Lane 1, P1 peptide alone. P1 after incubation with fraction
MiQ2 (lane 2) or with fraction MiQ2 in the presence of
inhibitors (lane 3-7) was as described under
"Experimental Procedures." cpi, carboxypeptidase
inhibitor; o-ph, ortho-phenanthroline; PMSF,
phenylmethylsulfonyl fluoride; NEM,
N-ethylmaleimide.

View larger version (22K):
[in a new window]
Fig. 7.
PreP-catalyzed degradation of the
N5.7pF1
-(2-54)-hsl
presequence that has a modified C terminus. Lane 1, an
N5.7pF1
-(2-54)-hsl alone.
N5.7pF1
(2-54)-hsl after incubation with
PreP-containing fraction (MiQ2) was as described under
"Experimental Procedures" (lane 2).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
subunit of the ATP synthase was rapidly degraded by a
matrix located protease(s) (27).
and F1
subunits of the ATP synthase, and Mn-SOD. These
proteins were excluded as protease candidates because they have well
characterized function and structures with no indication of a
proteolytic catalytic site. The 35-kDa protein could not be identified
by any means. It was visualized with Coomassie Blue but not with silver
staining, and no MALDI-TOF spectra could be obtained. These results may
indicate a non-proteinaceous nature of this spot. Two residual spots
were identified by ESI-MS/MS in order to obtain sequence information in
combination with molecular masses. ESI-MS/MS identified the 91-kDa
protein as a putative Hsp90 molecular chaperone, whereas the 105-kDa
protein was identified as a metalloprotease in the A. thaliana data bases. The identified metalloprotease harbored an
N-terminal mitochondrial targeting sequence, suggesting that it is
localized to mitochondria. The metalloprotease contained an inverted
zinc-binding motif (HILEHX74E) and
belongs to the pitrilysin family. Members of the pitrilysin family can
be divided into the pitrilysin subfamily, and the mitochondrial processing peptidase subfamily. The identified metalloprotease exhibits
high overall homology with proteases of the pitrilysin subfamily.
Members of the pitrilysin family are oligopeptidases of 100 kDa, such
as insulinase from mammals and its homologue in bacteria, protease III
(64). In the cell, these peptidases degrade small peptides of the
similar size as mitochondrial presequences (65). Interestingly,
insulinase was also found to degrade the cleaved leader peptide present
in a peroxisomal protein (66).
revealed no proteolytic fragments. It was evidenced
both upon immunodecoration of
N5.7pF1
-(2-54) with antibodies directed against its C-terminal part or when the
N15pF1
was labeled with sulfosuccinimidyl
biotin at lysines residues for detection with avidin peroxidase (27).
It has been reported that cleavage of chloroplastic transit peptides in
the stroma by stromal processing peptidase generates trimmed
peptide fragments (72).
presequence and the P1 peptide,
demonstrating the need of metals for proteolysis. A partial inhibition
of the activity was seen with a carboxypeptidase inhibitor; however,
the presequence with a modified C-terminal carboxyl group was
completely degraded by PreP indicating that there was no requirement of
a free C terminus for degradation. The carboxypeptidase inhibitor is a
peptide of 38 amino acids residues purified from potato and can thus
function as a competitive substrate in presequence degradation.
Classical protease inhibitors affecting serine and cysteine proteases
did not abolish the activity. No ATP dependence was shown for PreP.
Most proteases in the cell cleave substrates in an ATP-independent
manner. ATP is not required for peptide bond hydrolysis per
se but rather for unfolding or remodeling target substrates. The
lack of ATP dependence for presequence degradation might be due to the
fact that cleaved presequences are short, soluble peptides without
structure in an aqueous environment (15). In conclusion, we
characterize PreP as a metalloendopeptidase.
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 46-8-162457;
Fax: 46-8-153679; E-mail: e_glaser@dbb.su.se.
Published, JBC Papers in Press, July 23, 2002, DOI 10.1074/jbc.M205500200
2 A. Ståhl and E. Glaser, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: MPP, mitochondrial processing peptidase; SOD, superoxide dismutase; ESI/MS/MS, electrospray ionization-mass spectrometry/mass spectrometry; MALDI-TOF, matrix-assisted laser desorption ionization time-of-flight; DTT, dithiothreitol; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; hsl, homoserine lactone.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Paschen, S., and Neupert, W. (2001) IUBMB Life 522, 101-112 |
| 2. | Rehling, P., Wiedemann, N., Pfanner, N., and Truscott, K. (2001) Crit. Rev. Biochem. Mol. Biol. 36, 291-336[Abstract] |
| 3. |
Omura, T.
(1998)
J. Biochem. (Tokyo)
123,
1010-1016 |
| 4. | Rassow, J., and Pfanner, N. (2000) Traffic 1, 457-464[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Truscott, K., Pfanner, N., and Voos, W. (2001) Rev. Physiol. Biochem. Pharmacol. 143, 81-136[Medline] [Order article via Infotrieve] |
| 6. | Meisinger, C., Brix, J., Model, K., Pfanner, N., and Ryan, M. (1999) Cell. Mol. Life Sci. 30, 817-824 |
| 7. | Herrmann, J., and Neupert, W. (2000) Curr. Opin. Microbiol. 3, 210-214[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Zhang, X., Elofsson, A., Andreu, D., and Glaser, E. (1999) J. Mol. Biol. 23, 177-190 |
| 9. | Pfanner, N., and Geissler, A. (2001) Nat. Rev. Mol. Cell. Biol. 2, 339-349[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Glaser, E., and Dessi, P. (1999) J. Bioenerg. Biomembr. 31, 259-274[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Zhang, X., and Glaser, E. (2002) Trends Plant Sci. 7, 1-14[Medline] [Order article via Infotrieve] |
| 12. | Schneider, G., Sjoling, S., Wallin, E., Wrede, P., Glaser, E., and von Heijne, G. (1998) Proteins 30, 49-60[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | von Heijne, G. (1986) EMBO J. 5, 1335-1342[Medline] [Order article via Infotrieve] |
| 14. | Roise, D., Horvath, S., Tomich, J., Richards, J., and Schatz, G. (1986) EMBO J. 5, 1327-1334[Medline] [Order article via Infotrieve] |
| 15. | Hammen, P., Gorenstein, D., and Weiner, H. (1996) Biochemistry 26, 3772-3781 |
| 16. | Donate, F., Yanez, A., Iriarte, A., and Martinez-Carrion, M. (2000) J. Biol. Chem. 3, 34147-341156 |
| 17. | Goodfellow, B., Dias, J., Ferreira, G., Henklein, P., Wray, V., and Macedo, A. (2001) FEBS Lett. 14, 325-331 |
| 18. | Abe, Y., Shodai, T., Muto, T., Mihara, K., Torii, H., Nishikawa, S., Endo, T., and Kohda, D. (2000) Cell 3, 551-560 |
| 19. | Wieprecht, T., Apostolov, O., Beyermann, M., and Seelig, J. (2000) Biochemistry 19, 15297-15305 |
| 20. | Maduke, M., and Roise, D. (1993) Science 16, 364-367 |
| 21. | Zardeneta, G., and Horowitz, P. (1992) J. Biol. Chem. 5, 24193-24198 |
| 22. | Nicolay, K., Laterveer, F., and Heerde, W. (1994) J. Bioenerg. Biomembr. 26, 327-334[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Glaser, S., and Cumsky, M. (1990) J. Biol. Chem. 25, 8808-8816 |
| 24. | Lu, Y., and Beavis, A. (1997) J. Biol. Chem. 23, 13555-13561 |
| 25. | Matsuzaki, K., Murase, O., Fujii, N., and Miyajima, K. (1996) Biochemistry 3, 11361-11368 |
| 26. | Hugosson, M., Andreu, D., Boman, H., and Glaser, E. (1994) Eur. J. Biochem. 223, 1027-1033[Medline] [Order article via Infotrieve] |
| 27. | Ståhl, A., Pavlov, P., Szigyarto, C., and Glaser, E. (2000) Biochem. J. 349, 703-707[Medline] [Order article via Infotrieve] |
| 28. | Furuya, S., Mihara, K., Aimoto, S., and T, T. O. (1991) EMBO J. 10, 1759-1766[Medline] [Order article via Infotrieve] |
| 29. | Glaser, S., and Cumsky, M. (1990) J. Biol. Chem. 25, 8817-8822 |
| 30. | Ono, H., and Tuboi, S. (1988) J. Biol. Chem. 5, 3188-3193 |
| 31. | Brandt, U., Yu, L., Yu, C., and Trumpower, B. (1993) J. Biol. Chem. 25, 8387-8390 |
| 32. | Iwata, S., Lee, J., Okada, K., Lee, J., Iwata, M., Rasmussen, B., Link, T., Ramaswamy, S., and Jap, B. (1998) Science 3, 64-71 |
| 33. | Deng, K., Zhang, L., Kachurin, A., Yu, L., Xia, D., Kim, H., Deisenhofer, J., and Yu, C. (1998) J. Biol. Chem. 14, 20752-20757 |
| 34. | Kaser, M., and Langer, T. (2000) Semin. Cell Dev. Biol. 11, 181-190[CrossRef][Medline] [Order article via Infotrieve] |
| 35. | Langer, T. (2000) Trends Biochem. Sci. 25, 247-251[CrossRef][Medline] [Order article via Infotrieve] |
| 36. |
Klanner, C.,
Prokisch, H.,
and Langer, T.
(2001)
Mol. Biol. Cell
12,
2858-2869 |
| 37. | Leonhard, K., Herrmann, J., Stuart, R., Mannhaupt, G., Neupert, W., and Langer, T. (1996) EMBO J. 15, 4218-4229[Medline] [Order article via Infotrieve] |
| 38. | Shah, Z., Hakkaart, G., Arku, B., Jong, L. D., Spek, H. V. D., Grivell, L., and Jacobs, H. (2000) FEBS Lett. 4, 267-270 |
| 39. | Dyck, L. V., Neupert, W., and Langer, T. (1998) Genes Dev. 15, 1515-1524 |
| 40. | Savel'ev, A., Novikova, L., Kovaleva, I., Luzikov, V., Neupert, W., and Langer, T. (1998) J. Biol. Chem. 7, 20596-20602 |
| 41. |
Wang, N.,
Gottesman, S.,
Willingham, M. C.,
Gottesman, M. M.,
and Maurizi, M. R.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
11247-11251 |
| 42. |
Van Dyck, L.,
Pearce, D. A.,
and Sherman, F.
(1994)
J. Biol. Chem.
269,
238-242 |
| 43. | Barakat, S., Pearce, D. A., Sherman, F., and Rapp, W. D. (1998) Plant Mol. Biol. 37, 141-154[CrossRef][Medline] [Order article via Infotrieve] |
| 44. | Halperin, T., Zheng, B., Itzhaki, H., Clarke, A., and Adam, Z. (2001) Plant Mol. Biol. 45, 461-468[CrossRef][Medline] [Order article via Infotrieve] |
| 45. | Sagarra, M. D., Mayo, I., Marco, S., Rodriguez-Vilarino, S., Oliva, J., Carrascosa, J., and Castan, J. (1999) J. Mol. Biol. 1, 819-825 |
| 46. | Dyck, L. V., and Langer, T. (1999) Cell. Mol. Life Sci. 30, 825-842 |
| 47. | Pavlov, P., Moberg, P., Zhang, X., and Glaser, E. (1999) Biochem. J. 1, 95-103 |
| 48. | Laemmli, U. (1970) Nature 15, 680-685 |
| 49. | Lanne, B., Potthast, F., Höglund, A., Löwenhielm, H. B. V., Nyström, A., Nilsson, F., and Dahllöf, B. (2001) Proteomics 1, 819-828[CrossRef][Medline] [Order article via Infotrieve] |
| 50. | Kaiser, R., and Metzka, L. (1999) Anal. Biochem. 1, 1-8[Medline] [Order article via Infotrieve] |
| 51. | Eriksson, A. C., Sjöling, S., and Glaser, E. (1994) Biochim. Biophys. Acta 1186, 221-231 |
| 52. |
Stock, D.,
Leslie, A.,
and Walker, J.
(1999)
Science
286,
1700-1704 |
| 53. |
Millar, A.,
Sweetlove, L.,
Gieger, P.,
and Leaver, C.
(2001)
Plant Physiol.
127,
1711-1727 |
| 54. | Hartl, F. (1996) Nature 381, 571-579[CrossRef][Medline] [Order article via Infotrieve] |
| 55. | Matouschek, A., Pfanner, N., and Voos, W. (2000) EMBO Rep. 1, 404-410[CrossRef][Medline] [Order article via Infotrieve] |
| 56. | Fluckiger, S., Mittl, P., Scapozza, L., Fijten, H., Folkers, G., Grutter, M., Blaser, K., and Crameri, R. (2002) J. Immunol. 1, 1267-1272 |
| 57. | Cabezon, E., Runswick, M., Leslie, A., and Walker, J. (2001) EMBO J. 17, 6990-6996[CrossRef] |
| 58. | Zhu, X., Zhao, X., Burkhdder, W. F., Gragerov, A., Ogata, C., Gottesman, M., and Hendrickson, W. (1996) Science 14, 1606-1614[CrossRef] |
| 59. | Faure, M., Bourguignon, J., Neuburger, M., MacHerel, D., Sieker, L., Ober, R., Kahn, R., Cohen-Addad, C., and Douce, R. (2000) Eur. J. Biochem. 267, 2890-2898[Medline] [Order article via Infotrieve] |
| 60. | Leveque, V., Stroupe, M., Lepock, J., Cabelli, D., Tainer, J., Nick, H., and Silverman, D. (2000) Biochemistry 20, 7131-7137 |
| 61. | Ackrell, B. (2000) FEBS Lett. 466, 1-5[CrossRef][Medline] [Order article via Infotrieve] |
| 62. | Felts, S., Owen, B., Nguyen, P., Trepel, J., Donner, D., and Toft, D. (2000) J. Biol. Chem. 4, 3305-3312 |
| 63. | Ryan, C., Hass, G., and Kuhn, R. (1974) J. Biol. Chem. 10, 5495-5499 |
| 64. | Rawlings, N., and Barrett, A. (1991) Biochem. J. 15, 389-391 |
| 65. |
Duckworth, W.,
Bennett, R.,
and Hamel, F.
(1998)
Endocr. Rev.
19,
608-624 |
| 66. | Authier, F., Bergeron, J., Ou, W., Rachubinski, R., Posner, B., and Walton, P. (1995) Proc. Natl. Acad. Sci. U. S. A. 25, 3859-3863 |
| 67. | Mzhavia, N., Berman, Y., Qian, Y., Yan, L., and Devi, L. (1999) DNA Cell Biol. 18, 369-380[CrossRef][Medline] [Order article via Infotrieve] |
| 68. | Winzeler, E. (1999) Science 6, 901-906 |
| 69. | Maurizi, M. (1992) Experientia (Basel) 15, 178-201 |
| 70. | Young, L., Leonhard, K., Tatsuta, T., Trowsdale, J., and Langer, T. (2001) Science 16, 2135-2138 |
| 71. | Kuzela, S., and Goldberg, A. (1994) Methods Enzymol. 244, 376-383[Medline] [Order article via Infotrieve] |
| 72. | Richter, S., and Lamppa, G. (1999) J. Cell Biol. 4, 33-44 |
| 73. | Martoglio, B., and Dobberstein, B. (1998) Trends Cell Biol. 8, 410-415[CrossRef][Medline] [Order article via Infotrieve] |
| 74. | Gotoh, T., Sonoki, T., Nagasaki, A., Terada, K., Takiguchi, M., and Mori, M. (1996) FEBS Lett. 21, 119-122 |
| 75. | Tatoyan, A., and Giulivi, C. (1998) J. Biol. Chem. 1, 11044-11048 |
This article has been cited by other articles:
![]() |
A. Falkevall, N. Alikhani, S. Bhushan, P. F. Pavlov, K. Busch, K. A. Johnson, T. Eneqvist, L. Tjernberg, M. Ankarcrona, and E. Glaser Degradation of the Amyloid beta-Protein by the Novel Mitochondrial Peptidasome, PreP J. Biol. Chem., September 29, 2006; 281(39): 29096 - 29104. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bhushan, A. Stahl, S. Nilsson, B. Lefebvre, M. Seki, C. Roth, D. McWilliam, S. J. Wright, D. A. Liberles, K. Shinozaki, et al. Catalysis, Subcellular Localization, Expression and Evolution of the Targeting Peptides Degrading Protease, AtPreP2 Plant Cell Physiol., June 1, 2005; 46(6): 985 - 996. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Augustin, M. Nolden, S. Muller, O. Hardt, I. Arnold, and T. Langer Characterization of Peptides Released from Mitochondria: EVIDENCE FOR CONSTANT PROTEOLYSIS AND PEPTIDE EFFLUX J. Biol. Chem., January 28, 2005; 280(4): 2691 - 2699. [Abstract] [Full Text] [PDF] |